Literature DB >> 26543332

Circulating tumor cells isolation: the "post-EpCAM era".

Cristina Raimondi1, Chiara Nicolazzo1, Angela Gradilone1.   

Abstract

Circulating tumor cells (CTCs) represent a submicroscopic fraction detached from a primary tumor and in transit to a secondary site. The prognostic significance of CTCs in metastatic cancer patients was demonstrated for the first time more than ten years ago. To date, it seems clear enough that CTCs are highly heterogeneous and dynamically change their shape. Thus, the inadequacy of epithelial cell adhesion molecule (EpCAM) as universal marker for CTCs detection seems unquestionable and alternative methods able to recognize a broader spectrum of phenotypes are definitely needed. In this review the pleiotropic functions of EpCAM are discussed in detail and the role of the molecule in the biology of CTCs is critically dissected.

Entities:  

Keywords:  EpICD; Epithelial cell adhesion molecule (EpCAM); circulating tumor cells (CTCs); epithelial-mesenchymal transition

Year:  2015        PMID: 26543332      PMCID: PMC4626820          DOI: 10.3978/j.issn.1000-9604.2015.06.02

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  87 in total

1.  Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biology.

Authors:  Marco Wendel; Lyudmila Bazhenova; Rogier Boshuizen; Anand Kolatkar; Meghana Honnatti; Edward H Cho; Dena Marrinucci; Ajay Sandhu; Anthony Perricone; Patricia Thistlethwaite; Kelly Bethel; Jorge Nieva; Michel van den Heuvel; Peter Kuhn
Journal:  Phys Biol       Date:  2012-02-03       Impact factor: 2.583

2.  3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood.

Authors:  Siyang Zheng; Henry K Lin; Bo Lu; Anthony Williams; Ram Datar; Richard J Cote; Yu-Chong Tai
Journal:  Biomed Microdevices       Date:  2011-02       Impact factor: 2.838

3.  Circulating tumor cells: finding the needle in the haystack.

Authors:  Xiaoning Zhe; Michael L Cher; R Daniel Bonfil
Journal:  Am J Cancer Res       Date:  2011-06-01       Impact factor: 6.166

4.  Automated cellular sample preparation using a Centrifuge-on-a-Chip.

Authors:  Albert J Mach; Jae Hyun Kim; Armin Arshi; Soojung Claire Hur; Dino Di Carlo
Journal:  Lab Chip       Date:  2011-07-29       Impact factor: 6.799

5.  EpCAM regulates cell cycle progression via control of cyclin D1 expression.

Authors:  A Chaves-Pérez; B Mack; D Maetzel; H Kremling; C Eggert; U Harréus; O Gires
Journal:  Oncogene       Date:  2012-03-05       Impact factor: 9.867

6.  Immunobead-PCR: a technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction.

Authors:  J E Hardingham; D Kotasek; B Farmer; R N Butler; J X Mi; R E Sage; A Dobrovic
Journal:  Cancer Res       Date:  1993-08-01       Impact factor: 12.701

7.  Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.

Authors:  Matthew G Krebs; Jian-Mei Hou; Robert Sloane; Lee Lancashire; Lynsey Priest; Daisuke Nonaka; Tim H Ward; Alison Backen; Glen Clack; Andrew Hughes; Malcolm Ranson; Fiona H Blackhall; Caroline Dive
Journal:  J Thorac Oncol       Date:  2012-02       Impact factor: 15.609

8.  EpCAM nuclear localization identifies aggressive thyroid cancer and is a marker for poor prognosis.

Authors:  Ranju Ralhan; Jun Cao; Terence Lim; Christina Macmillan; Jeremy L Freeman; Paul G Walfish
Journal:  BMC Cancer       Date:  2010-06-25       Impact factor: 4.430

9.  Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer.

Authors:  Johann S de Bono; Howard I Scher; R Bruce Montgomery; Christopher Parker; M Craig Miller; Henk Tissing; Gerald V Doyle; Leon W W M Terstappen; Kenneth J Pienta; Derek Raghavan
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

10.  EpCAM proteolysis: new fragments with distinct functions?

Authors:  Ulrike Schnell; Jeroen Kuipers; Ben N G Giepmans
Journal:  Biosci Rep       Date:  2013-03-19       Impact factor: 3.840

View more
  11 in total

Review 1.  Liquid biopsy for lung cancer early detection.

Authors:  Mariacarmela Santarpia; Alessia Liguori; Alessandro D'Aveni; Niki Karachaliou; Maria Gonzalez-Cao; Maria Grazia Daffinà; Chiara Lazzari; Giuseppe Altavilla; Rafael Rosell
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

Review 2.  Evolution in Automatized Detection of Cells: Advances in Magnetic Microcytometers for Cancer Cells.

Authors:  Alexandre Chícharo; Diogo Miguel Caetano; Susana Cardoso; Paulo Freitas
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

3.  Is Ep-CAM Expression a Diagnostic and Prognostic Biomarker for Colorectal Cancer? A Systematic Meta-Analysis.

Authors:  Susu Han; Shaoqi Zong; Qi Shi; Hongjia Li; Shanshan Liu; Wei Yang; Wen Li; Fenggang Hou
Journal:  EBioMedicine       Date:  2017-05-24       Impact factor: 8.143

4.  Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients.

Authors:  Hanna Huebner; Peter A Fasching; Walter Gumbrecht; Sebastian Jud; Claudia Rauh; Mark Matzas; Peter Paulicka; Katja Friedrich; Michael P Lux; Bernhard Volz; Paul Gass; Lothar Häberle; Franziska Meier-Stiegen; Andreas Hartkopf; Hans Neubauer; Katrin Almstedt; Matthias W Beckmann; Tanja N Fehm; Matthias Ruebner
Journal:  BMC Cancer       Date:  2018-02-20       Impact factor: 4.430

5.  Long-Term Dynamics of Three Dimensional Telomere Profiles in Circulating Tumor Cells in High-Risk Prostate Cancer Patients Undergoing Androgen-Deprivation and Radiation Therapy.

Authors:  Landon Wark; Harvey Quon; Aldrich Ong; Darrel Drachenberg; Aline Rangel-Pozzo; Sabine Mai
Journal:  Cancers (Basel)       Date:  2019-08-14       Impact factor: 6.639

6.  Analysis of the Circulating Tumor Cell Capture Ability of a Slit Filter-Based Method in Comparison to a Selection-Free Method in Multiple Cancer Types.

Authors:  Hidenori Takagi; Liang Dong; Morgan D Kuczler; Kara Lombardo; Mitsuharu Hirai; Sarah R Amend; Kenneth J Pienta
Journal:  Int J Mol Sci       Date:  2020-11-27       Impact factor: 5.923

7.  MCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid Biopsy.

Authors:  Maria Cristina Rapanotti; Elisa Cugini; Marzia Nuccetelli; Alessandro Terrinoni; Cosimo Di Raimondo; Paolo Lombardo; Gaetana Costanza; Terenzio Cosio; Piero Rossi; Augusto Orlandi; Elena Campione; Sergio Bernardini; Marcel Blot-Chabaud; Luca Bianchi
Journal:  Int J Mol Sci       Date:  2021-11-17       Impact factor: 5.923

Review 8.  Future directions and management of liquid biopsy in non-small cell lung cancer.

Authors:  Alessia Maria Cossu; Marianna Scrima; Angela Lombardi; Anna Grimaldi; Margherita Russo; Alessandro Ottaiano; Michele Caraglia; Marco Bocchetti
Journal:  Explor Target Antitumor Ther       Date:  2020-08-31

9.  Circulating Tumor Cells (CTC) and Cell-Free DNA (cfDNA) Workshop 2016: Scientific Opportunities and Logistics for Cancer Clinical Trial Incorporation.

Authors:  Lori E Lowes; Scott V Bratman; Ryan Dittamore; Susan Done; Shana O Kelley; Sabine Mai; Ryan D Morin; Alexander W Wyatt; Alison L Allan
Journal:  Int J Mol Sci       Date:  2016-09-08       Impact factor: 5.923

Review 10.  Relevance of Circulating Tumor Cells as Predictive Markers for Cancer Incidence and Relapse.

Authors:  Chaithanya Chelakkot; Hobin Yang; Young Kee Shin
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.